Key facts
- Savana’s last known valuation is $47.4M (Oct 2020).
- It has raised $76.8M; the latest was Later Stage VC ($5.2M) in Jun 2025.
- Notable investors include INNVIERTE SICC, Cathay Innovation, Cathay Capital, Seaya Ventures, Buenavista Equity Partners — 13 tracked in total.
- Savana has filed 5 Form Ds with the SEC since 2009, most recently Jul 2022 ($45.2M sold to 12 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Savana
- ·The full record, as it builds
Funding rounds
No funding rounds for Savana are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Savana
Developer of an AI-based electronic health record platform designed to improve the quality of medical record management. The company's platform applies deep learning techniques to analyze the unstructured free text information written in electronic health records and automatically extracts valuable medical information, enabling medical professionals to improve clinical research and precision medicine by unlocking all of the clinical value in electronic records.
- Sector
- Healthcare
- HQ
- Madrid, Spain
- Founded
- 2014
- Employees
- 140
- Website
- savanamed.com/
- Ownership
- Privately Held (backing)
Savana doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Savana shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Savana in its N-PORT filings yet. We sweep new filings monthly.